Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs73097184 | chr12:52835842 | C/A | 0.000153 | 491 | 29.32 | 35.67 | 22.93 | KM Plot |
| PRAD | rs73097189 | chr12:52837769 | G/A | 0.000131 | 492 | 29.2 | 36.05 | 22.93 | KM Plot |
| PRAD | rs73097191 | chr12:52837780 | C/A | 0.000131 | 492 | 29.2 | 36.05 | 22.93 | KM Plot |
| PRAD | rs73097196 | chr12:52838156 | C/T | 0.000135 | 493 | 29.23 | 36.05 | 22.93 | KM Plot |
| PRAD | rs73099326 | chr12:52856095 | G/T | 8.61E-7 | 486 | 29.97 | 35.77 | 22.93 | KM Plot |
| PRAD | rs73103246 | chr12:52894113 | C/A | 0.000191 | 485 | 29.8 | 35.33 | 22.93 | KM Plot |
| PRAD | rs73149865 | chr12:129326378 | A/T | 4.04E-5 | 489 | 31.07 | 31.05 | 24 | KM Plot |
| PRAD | rs73161279 | chr2:10481001 | T/G | 1.05E-11 | 491 | 30.27 | 33.25 | 10.03 | KM Plot |
| PRAD | rs7322488 | chr13:96916634 | A/G | 0.000111 | 494 | 30.97 | 30.77 | 29.17 | KM Plot |
| PRAD | rs73236772 | chr6:170481781 | A/G | 2.85E-5 | 475 | 30.77 | 31.2 | 23.5 | KM Plot |
| PRAD | rs732691 | chr6:43240390 | C/T | 1.14E-7 | 488 | 31.37 | 28.07 | 21.57 | KM Plot |
| PRAD | rs73294088 | chr17:37805684 | G/A | 5.4E-6 | 493 | 30.8 | 33.05 | 28.63 | KM Plot |
| PRAD | rs73294092 | chr17:37808239 | G/A | 5.4E-6 | 493 | 30.8 | 33.05 | 28.63 | KM Plot |
| PRAD | rs73296106 | chr17:37815623 | G/A | 5.4E-6 | 493 | 30.8 | 33.05 | 28.63 | KM Plot |
| PRAD | rs73330342 | chr5:178983987 | A/G | 3.33E-11 | 482 | 30.8 | 36.33 | 15.87 | KM Plot |